CIK 0001651308 · Large accelerated filer
BeOne Medicines Ltd.
Sign in to watch- Ticker
- BEIGF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981209416
- Phone
- 41-616851900
- Business address
- C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
- Former names
- BeiGene, Ltd.
Securities
- ONC American Depositary Shares Nasdaq
- BEIGF Common stock OTC
- 8-K Event Other events
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- 4 Planned sale Chief Executive Officer sold 16,175 shares at an average $232.22 ($3,756,092)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Grant or award Director acquired 8,151 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Planned sale SVP, General Counsel sold 1,202 shares at $237.10 ($284,994)
- 4 Planned sale Global Head of R&D sold 5,000 shares at $220.35 ($1,101,774)
- 144 Insider Sale of Securities
- 8-K Event Other events
- 144 Insider Sale of Securities
- 8-K Event Executive or director change
- 4 Planned sale President, COO & GM China sold 5,000 shares at an average $200.12 ($1,000,615)
- 144 Insider Sale of Securities
- 4 Planned sale President, COO & GM China sold 5,556 shares at an average $189.65 ($1,053,677)
- 4 Open-market sale Principal Accounting Officer sold 137 shares at $189.94 ($26,022)
- UPLOAD Other SEC-generated Letter
- 144 Insider Sale of Securities
Page 18 of 64 · 1,278 filings